-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906. Outcomes Research—Malignant Conditions (Myeloid Disease): Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Biological, Coronaviruses, Leukemia, SARS-CoV-2/COVID-19, Diseases, Non-Biological, Elderly, Therapies, Adverse Events, chemotherapy, MPN, Polycythemia vera, thrombocythemia, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Vijaya R. Bhatt, MD1, Valerie K Shostrom2*, Nabin Khanal, MBBS3, Chakra P Chaulagain, MD4, Fiona He, MD5 and Krishna Gundabolu, MBBS6

1Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
2Univerisity of Nebraska Medical Center, Omaha, NE
3Franciscan Physician Network Oncology & Hematology Specialists, St Francis hospital, Indianapolis, IN
4Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL
5Unniversity of Minnesota, Minneapolis, MN
6Division of Oncology and Hematology, University of Nebraska Medical Center- Fred & Pamela Buffett Cancer Center, Omaha, NE

David Cella, PhD1*, Ellen Ritchie, MD 2, Arnaud Pigneux, MD, PhD3*, Yoshinobu Kanda, MD, PhD4, Cristina Ivanescu, PhD5*, Bhavik J. Pandya, PharmD6* and Manasee V. Shah, MPH6*

1Northwestern University, Feinberg School of Medicine, Chicago, IL
2Weill Cornell Medicine, New York, NY
3Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
4Jichi Medical University, Tochigi, Japan
5IQVIA, Amsterdam, Netherlands
6Astellas Pharma, Inc., Northbrook, IL

Daniel A. Pollyea, MD1, Maximilian Stahl2*, Chetasi Talati, MD3, Hannah Asghari, MD, BS3, Catherine Lai, MD, MPH4, Sameem Abedin, MD5, Joshua F. Zeidner, MD6, Benyam Muluneh, PharmD6*, Marin Xavier7*, Wesleigh Edwards, MD, PhD7, Ofir Wolach, MD8*, Yakir Moshe, MD, PhD9*, David Lavie, MD10*, Tsila Zuckerman, MD11, Michelle Choi12*, Cat N. Bui, PhD12*, Anders Erik Svensson, MD12*, Steve Kye, MD, MPH12, Rebecca Burne13*, Annie Guerin, MSc13*, Esprit Ma14*, Melissa Montez14* and Aaron D Goldberg, MD, PhD2

1University of Colorado School of Medicine, Aurora, CO
2Memorial Sloan Kettering Cancer Center, New York, NY
3Moffitt Cancer Center, Tampa, FL
4Medstar Georgetown University Hospital, Washington, DC
5Medical College of Wisconsin, Milwaukee, WI
6University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
7Scripps-MD Anderson, San Diego, CA
8Rabin Medical Center, Petah Tikva, Israel
9Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
10Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
11Rambam Health Care Campus, Haifa, Israel
12AbbVie Inc., North Chicago, IL
13Analysis Group, Inc., Montreal, QC, Canada
14Genentech, South San Francisco, CA

Lauren Willis, PharmD, BCOP1, Tristin Abair, PhD2* and Davecia R. Cameron, MSc2*

1Medscape Education, LLC, Lexington, KY
2Medscape Education, LLC, New York, NY

Thomas W. Leblanc1,2, Susan Morris3*, Michael Hooks3*, Susan C. Locke1* and Areej El-Jawahri4,5*

1Duke Cancer Institute, Durham, NC
2Duke University School of Medicine, Durham, NC
3Jazz Pharmaceuticals, Palo Alto, CA
4Massachusetts General Hospital, Boston, MA
5Harvard Medical School, Boston, MA

Daniel I. Nathan, MD1, Douglas Tremblay, MD2, Santiago Thibaud, MD2, John Mascarenhas, MD2 and Janice L. Gabrilove, MD2

1Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
2Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Samip R Master, MD1, Richard Preston Mansour, MD2 and Runhua Shi3*

1Louisiana State University Health Sciences Center, Shreveport, LA
2Louisiana State University Health Science Centre, shreveport, LA
3Louisiana State University Health Science Centre, Shreveport, LA

*signifies non-member of ASH